All Articles

ITRS's acquisition of French DEM leader IP-Label signals a major move to challenge market giants by creating a holistic observability platform for Europe.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

A new study on oral testosterone therapy for men 65-80 could reshape geriatric care, challenge FDA guidelines, and unlock a multi-billion dollar market.

The new venue near EpicCentral isn't just another opening; it's a strategic move in a competitive market, fueling local growth and redefining leisure.

As fraud losses top $43B, Vonage’s network-powered Identity Insights API wins a key award for redefining security and trust in the digital economy.

The firm is now recruiting for a Phase 1 trial of HWK-007 and has submitted an IND for HWK-016, targeting tough lung, ovarian, and endometrial cancers.

While humanoid robots grab headlines, Linkerbot quietly captured 80% of the dexterous hand market with revolutionary cost and production scale.

The cybersecurity firm renewed its multi-million dollar GRC contract with a Fortune 100 client, signaling deep trust and validating its market strategy.

As the AI arms race heats up, Lambda brings in veteran operator Leonard Speiser to lead its $1.5B+ expansion and build the future of AI supercomputing.

The LA Rams and energy firm CRC mark one year of a partnership to offset team emissions, but does this innovative, local-first model truly change the game?

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

The deal integrates specialized AI and therapist-led platforms to boost mental health access for remote communities and spearhead global expansion.

The hospitality tech giant is leveraging its platform with a new AI assistant for retailers, aiming to automate inventory, boost margins, and challenge market leaders.

With pivotal data for its sickle cell drug and a new myelofibrosis program, Cellarity's AI-driven 'Cell State-Correcting' platform faces a crucial test.

Vuzix wins a CES 2026 Innovation Award for its Ultralite Pro, smart glasses so discreet they look ordinary but pack powerful AI for the enterprise.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

Safi Biotherapeutics and ARMI | BioFabUSA achieve a critical step toward mass-producing red blood cells, offering hope for patients and military readiness.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

The biotech firm launches an early access program for its novel platform, starting with a tau assay that could revolutionize Alzheimer's research.

A new partnership leverages in vivo screening to find novel obesity targets, aiming to revolutionize a market projected to exceed $100 billion.